JP2024546842A5 - - Google Patents
Info
- Publication number
- JP2024546842A5 JP2024546842A5 JP2024535370A JP2024535370A JP2024546842A5 JP 2024546842 A5 JP2024546842 A5 JP 2024546842A5 JP 2024535370 A JP2024535370 A JP 2024535370A JP 2024535370 A JP2024535370 A JP 2024535370A JP 2024546842 A5 JP2024546842 A5 JP 2024546842A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- protein according
- domain
- antibody
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163289595P | 2021-12-14 | 2021-12-14 | |
| US63/289,595 | 2021-12-14 | ||
| US202263368119P | 2022-07-11 | 2022-07-11 | |
| US63/368,119 | 2022-07-11 | ||
| PCT/US2022/081559 WO2023114847A2 (en) | 2021-12-14 | 2022-12-14 | Compositions and methods for treating disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546842A JP2024546842A (ja) | 2024-12-26 |
| JP2024546842A5 true JP2024546842A5 (https=) | 2025-12-17 |
Family
ID=85157400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535370A Pending JP2024546842A (ja) | 2021-12-14 | 2022-12-14 | 疾患を治療するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250129136A1 (https=) |
| EP (1) | EP4448561A2 (https=) |
| JP (1) | JP2024546842A (https=) |
| KR (1) | KR20240125951A (https=) |
| AU (1) | AU2022409708A1 (https=) |
| CA (1) | CA3240528A1 (https=) |
| WO (1) | WO2023114847A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023183474A1 (en) * | 2022-03-23 | 2023-09-28 | Bodhi Bio Llc | Antigen-specific therapy for autoimmune diseases |
| WO2024189620A1 (en) * | 2023-03-13 | 2024-09-19 | Canopy Immuno-Therapeutics Ltd. | Ig-like fusion proteins for treating pemphigus vulgaris and foliaceus |
| WO2025253854A1 (ja) * | 2024-06-04 | 2025-12-11 | 国立大学法人京都大学 | Ｂ細胞受容体を発現する細胞の傷害及び／又は除去剤、該剤を含む自己免疫疾患の治療剤及び医薬組成物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| US5350741A (en) | 1988-07-30 | 1994-09-27 | Kanji Takada | Enteric formulations of physiologically active peptides and proteins |
| JPH0977800A (ja) * | 1995-09-12 | 1997-03-25 | Takeji Nishikawa | 融合蛋白質、並びに落葉状天疱瘡の治療薬、治療器具、診断剤及び抗体測定方法 |
| AU2001295503A1 (en) | 2000-08-22 | 2002-03-04 | Micromet Ag | Composition for the elimination of autoreactive b-cells |
| EP2050466B1 (en) * | 2006-08-14 | 2015-10-28 | Chugai Seiyaku Kabushiki Kaisha | Diagnosis and treatment of cancer using anti-desmoglein-3 antibodies |
| EP2123754B1 (en) * | 2007-01-30 | 2011-04-06 | Forerunner Pharma Research Co., Ltd. | CHIMERIC Fc GAMMA RECEPTOR AND METHOD FOR DETERMINATION OF ADCC ACTIVITY BY USING THE RECEPTOR |
-
2022
- 2022-12-14 EP EP22851303.2A patent/EP4448561A2/en active Pending
- 2022-12-14 US US18/719,811 patent/US20250129136A1/en active Pending
- 2022-12-14 CA CA3240528A patent/CA3240528A1/en active Pending
- 2022-12-14 AU AU2022409708A patent/AU2022409708A1/en active Pending
- 2022-12-14 JP JP2024535370A patent/JP2024546842A/ja active Pending
- 2022-12-14 KR KR1020247023344A patent/KR20240125951A/ko active Pending
- 2022-12-14 WO PCT/US2022/081559 patent/WO2023114847A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240124584A1 (en) | Igm fc and j-chain mutations that affect igm serum half-life | |
| JP2024546842A5 (https=) | ||
| CN112119097B (zh) | 自然杀伤细胞接合抗体融合构建体 | |
| KR102745676B1 (ko) | 항-bcma 중쇄-단독 항체 | |
| TWI373343B (en) | Antibodies that bind human interleukin-18 and methods of making and using | |
| US9908938B2 (en) | Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof | |
| RU2770209C2 (ru) | Терапевтические антитела против лиганда cd40 | |
| CN113710707A (zh) | 结合于psma的重链抗体 | |
| EP1260521A2 (en) | Immunoglobulin variants for specific Fc epsilon receptors | |
| JP2005538706A (ja) | スーパーヒト化抗体 | |
| CN109219617A (zh) | Bcma和cd3双特异性t细胞接合抗体构建体 | |
| CN109476734A (zh) | Cd70和cd3的抗体构建体 | |
| CN105531370A (zh) | 治疗靶向特异性vnar结构域与icosl的分离 | |
| US20230212293A1 (en) | Pd-1 agonist multimeric binding molecules | |
| US12378326B2 (en) | Anti-CD28 x anti-PSMA antibodies | |
| JP6966330B2 (ja) | Ｉｉｉ型分泌装置標的化分子 | |
| JP7080219B2 (ja) | 共刺激受容体およびチェックポイント受容体に連結する二重特異性免疫調節抗体 | |
| US20230383012A1 (en) | Antibodies that bind pd-l1, pd-l2, and/or cd28 | |
| US20220306760A1 (en) | Igm glycovariants | |
| JP6640232B2 (ja) | クロストリジウム・ディフィシル感染症の治療のための、クロストリジウム・ディフィシルのトキシンａ及びトキシンｂに対する四重特異性の八量体型結合剤及び抗体 | |
| AU2019277546A1 (en) | Nav1.7 monoclonal antibody | |
| US20250122299A1 (en) | ANTI-CD20 x ANTI-CD28 COMBINATION THERAPIES | |
| JP2007527703A (ja) | 肺炎球菌表面付着因子Ａタンパク質（ＰｓａＡ）に関する結合メンバー | |
| TW202144425A (zh) | 特異性抗原結合分子，其製備方法及醫藥用途 | |
| WO2024094151A1 (en) | Multi-specific antibody and medical use thereof |